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Disruption of functional connectivity between brain regions may represent an early functional consequence of b-amyloid path-
ology prior to clinical Alzheimer’s disease. We aimed to investigate if non-demented older individuals with increased amyloid
burden demonstrate disruptions of functional whole-brain connectivity in cortical hubs (brain regions typically highly connected
to multiple other brain areas) and if these disruptions are associated with neuronal dysfunction as measured with
ﬂuorodeoxyglucose-positron emission tomography. In healthy subjects without cognitive symptoms and patients with mild
cognitive impairment, we used positron emission tomography to assess amyloid burden and cerebral glucose metabolism,
structural magnetic resonance imaging to quantify atrophy and novel resting state functional magnetic resonance imaging
processing methods to calculate whole-brain connectivity. Signiﬁcant disruptions of whole-brain connectivity were found in
amyloid-positive patients with mild cognitive impairment in typical cortical hubs (posterior cingulate cortex/precuneus), strongly
overlapping with regional hypometabolism. Subtle connectivity disruptions and hypometabolism were already present in
amyloid-positive asymptomatic subjects. Voxel-based morphometry measures indicate that these ﬁndings were not solely a
consequence of regional atrophy. Whole-brain connectivity values and metabolism showed a positive correlation with each
other and a negative correlation with amyloid burden. These results indicate that disruption of functional connectivity and
hypometabolism may represent early functional consequences of emerging molecular Alzheimer’s disease pathology, evolving
prior to clinical onset of dementia. The spatial overlap between hypometabolism and disruption of connectivity in cortical hubs
points to a particular susceptibility of these regions to early Alzheimer’s-type neurodegeneration and may reﬂect a link between
synaptic dysfunction and functional disconnection.
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Introduction
The aggregation of b-amyloid peptides has been hypothesized to
be causally involved in the genesis of Alzheimer’s disease (Braak
et al., 1999). It has been suggested that neurotoxic amyloid ag-
gregates may lead to synaptic dysfunction and eventually synaptic
loss (Selkoe, 2008). Disruption of functional connectivity between
brain regions may represent an early deleterious consequence of
these synaptic pathologies, potentially occurring prior to neuronal
death and atrophy (Greicius et al., 2004; Rombouts et al., 2005;
Hedden et al., 2009; Sheline et al., 2010).
Multimodal imaging offers a unique opportunity to explore the
interrelation and overlap between molecular key pathologies and
their functional consequences in vivo, even in very early stages of
Alzheimer’s disease. Characteristic ﬁndings have been reported
with different imaging techniques in dementia of the Alzheimer’s
type as well as in predementia stages of disease, such as in mild
cognitive impairment and even in healthy at-risk people: increased
b-amyloid burden can be measured by
11C-Pittsburgh compound
B (PiB)-PET, regional atrophy by structural MRI and reduced neur-
onal activity is reﬂected in cerebral hypometabolism as measurable
by
18F-ﬂuorodeoxyglucose-PET (Silverman et al., 2001; Chetelat
et al., 2003; Minoshima, 2003; Kantarci and Jack, 2004; Mosconi
et al., 2004; Dickerson et al., 2005; Drzezga et al., 2005; Mintun
et al., 2006; Pike et al., 2007; Drzezga, 2008; Okello et al., 2009).
Recent advances in imaging now allow the assessment of func-
tional connectivity. By measuring the correlation of spontaneous
low-frequency activity with resting-state blood oxygen
level-dependent functional MRI techniques, synchronously active
regions in the brain can be identiﬁed, indicating functional inter-
action of the involved regions (Biswal et al., 1995). This technique
does not require a cognitive task or active participation by the
subject, which may decrease variability due to differences in com-
pliance or performance. Synchronously active brain regions identi-
ﬁed by this technique are commonly referred to as ‘resting-state
networks’. The most prominent example of such a network is the
so-called ‘default mode network’ (Gusnard and Raichle, 2001;
Raichle et al., 2001). The default mode network includes the pos-
terior cingulate cortex and medial prefrontal, hippocampal and
inferior parietal cortical regions, and has been associated with
the processing of internally focused cognitive tasks (Buckner
et al., 2008). Interestingly, a striking topographical resemblance
of the default mode network has been described with pathological
ﬁndings in Alzheimer’s disease, i.e. regional hypometabolism,
amyloid deposition and regional atrophy (Buckner et al., 2005,
2009). Reductions of functional connectivity within the default
mode network have been demonstrated in Alzheimer’s disease
and mild cognitive impairment, particularly in posterior cingulate
cortex/precuneus regions (Greicius et al., 2004; Rombouts et al.,
2005; Sorg et al., 2007; Fleisher et al., 2009). The striking
anatomic overlap in the pattern of alterations in Alzheimer’s dis-
ease across these imaging modalities may indicate an interrelation
between different pathomechanisms. Recent studies have shown
an association between default mode network disruption and
amyloid burden in healthy elderly subjects during task (Sperling
et al., 2009) and rest conditions (Hedden et al., 2009; Sheline
et al., 2010). However, the association between alterations in
synaptic function, functional connectivity and amyloid burden
still remains to be elucidated. Typically, resting-state networks
have been detected by the identiﬁcation of brain regions function-
ally connected to a speciﬁc seed region (e.g. the posterior cingu-
late cortex) or by means of independent component analysis
(Calhoun et al., 2001; Beckmann et al., 2005; Vincent et al.,
2006; Buckner et al., 2008). These strategies allow the identiﬁca-
tion of speciﬁc separate networks but they do not provide inde-
pendent information with regard to the regional degree of
connectivity in any given region in the brain. This fact considerably
limits the comparability of functional connectivity ﬁndings with
results from other imaging modalities such as
ﬂuorodeoxyglucose-PET. This limitation may be overcome by re-
cently introduced ‘cortical hub analysis’ of resting-state functional
MRI data, which allows identiﬁcation of the number of function-
ally connected voxels for every single voxel in the brain. In this
technique, the time course of the blood oxygen level-dependent
signal in a target voxel is extracted and correlated to the time
course of every other voxel across the entire brain, yielding a
whole-brain connectivity value, based on the number of voxels
it is strongly correlated with (Buckner et al., 2009; Sepulcre
et al., 2010). Regions that are functionally connected to many
other brain regions are referred to as ‘cortical hubs’. It has been
speculated that cortical hubs may play an important role in mod-
erating inter-regional neuronal communication (Buckner et al.,
2009; Tomasi and Volkow, 2010).
Previous work from our group suggested that the anatomic dis-
tribution of amyloid burden in patients with Alzheimer’s disease
overlapped with the cortical hub regions with highest cortical con-
nectivity in young subjects (Buckner et al., 2009). We aimed to
test the premise that increasing amyloid burden in the brain leads
to synaptic dysfunction in cortical hubs, resulting in decreased
regional neuronal activity and functional disconnection of these
regions. Based on results from previous unimodal imaging studies,
we speculated that abnormalities would converge particularly in
the posterior cingulate cortex/precuneus region, potentially prior
to the clinical onset of dementia. To our knowledge, changes
in cortical hub integrity have not yet been documented in
Alzheimer’s disease, mild cognitive impairment or amyloid-positive
healthy controls. We employed a multimodal imaging approach in
groups of asymptomatic healthy older adults with and without
amyloid pathology and also in amyloid-positive subjects with
mild cognitive impairment, in order to investigate the relationship
1636 | Brain 2011: 134; 1635–1646 A. Drzezga et al.between amyloid burden, local neuronal function and whole-brain
functional connectivity in predementia stages of Alzheimer’s
disease.
Materials and methods
Subject inclusion
The subjects included in this study were selected from a larger popu-
lation of 76 subjects who had participated in an ongoing study on
cognition and ageing at Brigham and Women’s Hospital and
Massachusetts General Hospital, including a multimodal imaging proto-
col consisting of
18F-ﬂuorodeoxyglucose-PET,
11C-PiB-PET, structural
MRI and resting state functional MRI, as well as detailed neuropsycho-
logical evaluation (for detailed in/exclusion criteria see Supplementary
Material). From this population, we aimed to select three groups of
subjects: (i) healthy older controls without cortical uptake of
11C-PiB
(PiB-negative), i.e. subjects without evidence of pathological cortical
amyloid deposition; (ii) PiB-positive healthy control subjects and (iii)
PiB-positive subjects with mild cognitive impairment, representing a
high-risk population for Alzheimer’s disease.
Only amyloid-positive patients with mild cognitive impairment were
selected, to avoid inclusion of subjects potentially suffering from dis-
orders other than Alzheimer’s disease (Cohen et al., 2009). Clinical
classiﬁcation was performed employing established criteria (see
Supplementary material) and classiﬁcation into PiB-positive or PiB-
negative was performed on the basis of pre-established thresholds of
cortical
11C-PiB distribution, as described below (Johnson et al., 2007;
Gomperts et al., 2008; Hedden et al., 2009). For statistical purposes,
we tried to select as large as possible groups from the pre-existing
population, with the constraint that the three groups would not differ
with regard to age, level of education, time intervals between their
examinations and that they had successfully undergone all imaging
procedures and completed all neuropsychological tests.
All subjects provided written informed consent prior to any experi-
mental procedures in accordance with protocols approved by the
Partners Healthcare Inc. Institutional Review Board. The study was
approved by and conducted under the auspices of the Partners
Human Research Committee at Brigham and Women’s Hospital and
Massachusetts General Hospital. A subset of data on PiB-positive and
PiB-negative healthy controls as well as from eight subjects with mild
cognitive impairment in this study have been included in previous
publications (Hedden et al., 2009; Sperling et al., 2009). However,
neither the whole-brain connectivity analysis of resting-state functional
MRI, nor the ﬂuorodeoxyglucose-PET data in these subjects, nor any
cross-modal interaction between these imaging parameters or their
association with amyloid load has been published previously.
Image acquisition and analysis
All acquisition, preprocessing and image analysis procedures of struc-
tural MRI, functional MRI,
18F-ﬂuorodeoxyglucose-PET and
11C-PiB-
PET were conducted using standard procedures as published previously
(see below for detailed references).
Magnetic resonance imaging
All MRI-data were acquired on a Siemens Trio 3.0 T MRI-scanner
(Siemens Medical Systems) as published previously (Sperling et al.,
2009). For structural MRI/voxel-based morphometry, high-resolution
T1-weighted structural images were acquired [3D magnetization
prepared rapid acquisition gradient echo (MP-RAGE) sequences: repe-
tition time = 2530ms, echo time = 3.45ms, inversion time = 1100ms,
ﬂip angle = 7, ﬁeld of view = 256mm, matrix 192  256, slice thick-
ness = 1.33mm, 128 sagittal slices]. Preprocessing of structural MRI
data and voxel-based morphometry analysis was carried out using
SPM5 software as recently reported (Drzezga et al., 2009).
T1-weighted high-resolution structural MRI data were spatially normal-
ized to the MRI Montreal Neurological Institute template in SPM5 and
warping parameters were collected for later normalization of PET data
(Drzezga et al., 2008). Default SPM5 software was used, applying the
uniﬁed segmentation process (Ashburner and Friston, 2005) and
images were segmented into grey and white matter and CSF. Then,
the modulated grey matter images were selected for further analysis.
Voxel-by-voxel t-tests were applied to detect grey matter differences
between the different subject groups (Sorg et al., 2007). This ap-
proach has been previously demonstrated to be suitable for voxel-
based morphometry analysis of patients with dementia, even with
marked brain atrophy (Jack et al., 2008) (see also Supplementary
material).
For resting functional MRI, blood oxygen level-dependent functional
MRI data were acquired using a T2*-weighted gradient echo echo-
planar imaging (EPI) sequence: repetition time = 2000ms, echo time =
30ms, ﬂip angle = 90, ﬁeld of view = 200mm, matrix = 64  64.
Thirty slices oriented perpendicular to the anterior–posterior commis-
sure line, with 5-mm thick slices and 1-mm gap and 3.125 
3.125mm in-plane resolution, were acquired in each of the functional
volumes, with 195 whole-brain volumes acquired in the run. Five
‘dummy’ scans were collected at the beginning of the resting run to
allow for T1 equilibration effects. The resting run lasted 6min 40s.
During the resting run, subjects were instructed to ﬁxate on a visual
white cross-hair, centred on a black background. Functional MRI pre-
processing included compensation of systematic, slice-dependent time
shifts, motion correction and normalization to the atlas space of the
Montreal Neurological Institute (SPM2; Wellcome Department of
Cognitive Neurology) resulting in volumetric time series resampled at
2mm cubic voxels. Temporal ﬁltering retained frequencies below
0.08Hz, spatial smoothing was performed using a 4-mm full-width
half maximum Gaussian blur. Non-speciﬁc variance was removed by
regression of nuisance variables such as head motion, signal averaged
over whole brain, ventricles and white matter (for details see
Supplementary Material).
Functional connectivity analysis (cortical hub analysis) was carried
out in the current study as previously reported (Buckner et al.,
2009). The time course of the blood oxygen level-dependent signal
in a target voxel was extracted and correlated to the time course of
every other voxel across the entire brain (Buckner et al., 2009). The
number of strongly connected voxels was then assigned to this target
voxel as whole-brain connectivity value. This procedure was repeated
for every voxel in the brain and a whole-brain connectivity map,
showing the degree values of whole-brain connectivity for every
voxel in the brain, was produced for every subject, with a high
whole-brain connectivity value representing high connectivity to the
rest of the brain. These maps formed the basis for further statistical
analyses.
Positron emission tomography
All PET scans were acquired on a Siemens/CTI ECAT HR
+ PET scanner
as described below. Amyloid imaging was performed with
N-methyl-
11C-2-(4-methylaminophenyl)-6-hydroxybenzothiazole (PiB).
11C-PiB was prepared as described by Mathis et al. (2002) and PiB-
PET scans were acquired at Massachusetts General Hospital, as previ-
ously described (Johnson et al., 2007; Gomperts et al., 2008; Hedden
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15mCi
11C-PiB was injected as a bolus intravenously and followed
immediately by a 60-min dynamic PET scan in 3D mode (63 image
planes, 15.2cm axial ﬁeld of view, 5.6mm transaxial resolution and
2.4mm slice interval; 69 frames: 12  15s, 57  60s). PiB-PET data
were reconstructed with ordered set expectation maximization, cor-
rected for attenuation and each frame was evaluated to verify ad-
equate count statistics and absence of head motion. Individual
11C-PiB-PET scans were spatially normalized using the warping infor-
mation derived from individual stereotactic normalization of the struc-
tural MRI using SPM 5. The Logan graphical analysis method was used
to calculate distribution volume ratios, with the cerebellar cortex as the
reference tissue (Price et al., 2005). In analogy to previously published
studies (Hedden et al., 2009), a pre-established large cortical volume
of interest consisting of frontal, lateral parietal and lateral temporal
and retrosplenial cortices (FLR-VOI) was used to evaluate amyloid
burden. Distribution volume ratios were calculated, using the cerebellar
cortex as the reference tissue and previously published cut-off values
were used to divide between PiB-positive (51.15) and PiB-negative
(51.15) subjects (Johnson et al., 2007; Gomperts et al., 2008;
Hedden et al., 2009).
For
18F-ﬂuorodeoxyglucose-PET imaging, 5.0  1.0mCi was intra-
venously injected while subjects were quietly resting. After a 45-min
uptake period ﬂuorodeoxyglucose-PET images were acquired for
30min in 3D mode, following a transmission scan. Image processing
was carried following previously established protocols (Drzezga et al.,
2008; Yakushev et al., 2008) including normalization and spatial warp-
ing using SPM5 software (Friston et al., 1995). These normalized scans
were then used for further statistical analyses.
Statistical analysis
Group comparisons
Voxel-based group comparisons were carried out using voxel-by-voxel
two-sample t-tests (unpaired) in SPM5, as performed in previous stu-
dies (Ashburner and Friston, 2005; Ziolko et al., 2006; Drzezga et al.,
2008, 2009; Jack et al., 2008). In prior studies, a strong regional
overlap between the typical anatomy of the default mode network
in healthy controls and the typical patterns of atrophy and hypome-
tabolism in Alzheimer’s disease has been noted (Buckner et al., 2005).
Interestingly, a strong anatomic overlap between these patterns and
the location of the major cortical hub regions, as identiﬁed by
whole-brain connectivity analysis in healthy control subjects, has also
been demonstrated (Buckner et al., 2009). Consequently, we expected
that our ﬁndings would also be located within this cerebral network. In
detail, this network of expected abnormalities included the following
regions: ventral medial prefrontal cortex [Brodmann areas (BA) 24, 10,
32], posterior cingulate cortex/precuneus (BA 29, 30, 23, 31, 7), in-
ferior parietal lobule/angular gyrus (BA 39, 40), lateral temporal cortex
(BA 21), dorsal medial prefrontal cortex (BA 24, 32, 9, 10) and the
hippocampal formation [for detailed reference see Table 1 in Buckner
et al. (2008)]. Within this predeﬁned network, we applied a signiﬁ-
cance threshold of P50.001 (uncorrected) across all imaging modal-
ities, to allow comparability of the results, as previously published
(Sperling et al., 2009). An extent threshold of 30 contiguous voxels
was selected.
According to our hypothesis, we expected abnormalities, particularly
in the posterior cingulate cortex/precuneus region. Thus, we employed
an independently predeﬁned spherical volume in the posterior
cingulate cortex for volumes of interest-based group comparison
(Andrews-Hanna et al., 2007). For this analysis a signiﬁcance threshold
of P50.05 was used.
Cross modality/correlation analyses
To quantitatively evaluate the topographical overlap between the pat-
terns of whole-brain connectivity disruption and hypometabolism in
mild cognitive impairment, we calculated a dice coefﬁcient of similarity
between the two ﬁndings (Zou et al., 2004).
Pearson correlation coefﬁcients were calculated between values
measured within the predeﬁned volumes of interest (posterior cingu-
late cortex, FLR-VOI). Correlations were regarded signiﬁcant above a
threshold of P50.05. Additionally, correlation analyses between ima-
ging and non-imaging ﬁndings were performed and voxel-based cor-
relation analyses between imaging modalities were employed for
regionally unrestricted correlation analysis (see Supplementary
Material). For further detailed description of statistical methods refer
to the Supplementary Material.
Results
Subject characteristics
On the basis of the preconditions mentioned above, we were able
to collect data from 37 older subjects (mean age 74.0  6.3)
(Table 1), which included 24 cognitively normal healthy controls
classiﬁed as PiB-positive (n=12) or PiB-negative (n=12). Thirteen
of the subjects were PiB-positive with mild cognitive impairment
Table 1 Subject characteristics
Characteristics PiB-negative
healthy controls
PiB-positive
healthy controls
PiB-positive patients
with mild cognitive
impairment
n (female/male) 12 (7/5) 12 (8/4) 13 (4/9)
PiB-FLR (mean  SD) 1.07  0.05 1.35  0.20* 1.58  0.34
#,*
Age (mean  SD) 71.3  6.3 74.5  5.7 75.9  6.4
Clinical Dementia Rating Scale—global 0 0 0.5
Clinical Dementia Rating Scale—sum of boxes (mean  SD) 0 0 1.83  1.17
#,*
MMSE (mean  SD) 28.92  0.79 29.42  0.79 27.5  2.43
#
Years of education (mean  SD) 17.36  1.69 15.75  3.17 17.75  2.70
*Signiﬁcant as compared to PiB-negative controls (P50.05);
#Signiﬁcant as compared to PiB-positive controls (P50.05).
MMSE = Mini Mental State Examination.
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to the PiB-FLR values, with the highest mean tracer uptake in
subjects with mild cognitive impairment, followed by PiB-positive
healthy controls and PiB-negative healthy controls (Table 2). The
mean time span between the ﬁrst and last imaging modality was
4.9  1.8 months, and did not differ between the groups. There
were no signiﬁcant differences between the groups with regard
to level of education and age. Nevertheless, age was included
as covariate into the statistical analyses, as amyloid deposition is
thought to be related to advancing age, and because the mean
age was numerically highest in mild cognitive impairment, fol-
lowed by PiB-positive healthy controls and PiB-negative healthy
controls.
Voxel-based group comparisons
The whole-brain connectivity in the group of PiB-negative healthy
controls revealed areas with a high degree of whole-brain con-
nectivity (cortical hubs) distributed in a similar pattern as described
in a previous study in healthy younger adults (Buckner et al.,
2009), with maxima in medial prefrontal cortex, bilateral par-
ietal/angular cortex, posterior cingulate cortex/precuneus and
bilateral lateral temporal cortex (Fig. 1A and Supplementary
Table 1). In contrast, the PiB-positive healthy control group
demonstrated no signiﬁcant whole-brain connectivity clusters in
right angular and posterior cingulate cortex/precuneus cortical
hub regions and whole-brain connectivity clusters were completely
absent in bilateral angular and posterior cingulate cortex/
precuneus regions in the mild cognitive impairment group.
Correspondingly, statistical comparison between the groups re-
vealed a reduced degree of whole-brain connectivity in mild
cognitive impairment as compared to PiB-negative healthy controls
in posterior cortical hub regions, including angular, lateral temporal
and the posterior cingulate cortex/precuneus regions (Fig. 1B and
Supplementary Table 2). Whole-brain connectivity disruptions in
left lateral temporal cortical regions were also detected in mild
cognitive impairment as compared to PiB-positive healthy controls
(Supplementary Fig. 1B and Supplementary Table 2). PiB-positive
healthy controls revealed decreased whole-brain connectivity com-
pared with PiB-negative healthy controls in right-hemispheric lat-
eral temporal cortex, extending into the posterior cingulate cortex
(Supplementary Fig. 1B and Supplementary Table 2).
In the
18F-ﬂuorodeoxyglucose-PET studies, statistical voxel-
based group comparison between subjects with mild cognitive im-
pairment and PiB-negative healthy controls revealed signiﬁcant
hypometabolism in subjects with mild cognitive impairment in
dorsal brain regions, including posterior cingulate cortex/precu-
neus and extending into lateral temporal cortical areas (Fig. 1B
and Supplementary Table 2). The topography of these abnormal-
ities in subjects with mild cognitive impairment showed distinct
anatomical overlap with the whole-brain connectivity abnormal-
ities detected in the same group (Figs 1B and 2; Supplementary
Table 2). Comparing subjects with mild cognitive impairment
to PiB-positive healthy controls, hypometabolic changes were
observed in subjects with mild cognitive impairment in the precu-
neus, resembling the pattern detected in comparison with
PiB-negative healthy controls (Supplementary Fig. 1A and
Supplementary Table 2). Comparison between PiB-positive healthy
controls and PiB-negative healthy controls revealed only a small
cluster of lower metabolism in right frontal cortex in PiB-positive
healthy controls [Talairach coordinates (x, y, z): 56, 16, 26, z-score
3.99], which was outside of our network of expected
Table 2 Group comparison of values as measured in different imaging modalities by volume of interest-based analysis and
volume of interest-based correlation analysis of values as measured in different imaging modalities in the entire sample
Groups/comparisons PiB FDG WBC VBM
Volume of interest-based group comparison*
Groups
HC-PiB
 1.07  0.05 65.67  3.92 0.37  0.69 86.15  2.94
HC-PiB
+ 1.35  0.2 62.13  3.34 0.06  0.52 86.39  5.10
MCI 1.58  0.34 60.07  3.80  0.19  0.37 85.23  4.66
t-tests (P-values)
HC-PiB
 versus MCI 50.001 0.001 0.021 0.897
HC-PiB
+ versus MCI 0.05 0.164 0.183 0.577
HC-PiB
 versus HC-PiB
+ 50.001 0.027 0.241 0.581
Correlation analyses No correction Age corrected Atrophy corrected
FDG WBC FDG WBC FDG WBC
Volumes of interest-based correlation analysis
#
PiB 0.56 0.36 0.57 0.29 0.53 0.36
FDG – 0.33 – 0.33 – 0.35
*Values are given as mean  standard deviation.
#Values represent the Pearson correlation-coefﬁcient, signiﬁcance threshold: P50.05 (two-tailed).
FDG =
18F-ﬂuorodeoxyglucose-PET values in the spherical volume of interest in posterior cingulate cortex (posterior cingulate cortex-volume of interest); PiB =
11C-PiB-PET
values measured in the large cortical FLR-VOI; VBM = voxel-based morphometry values in the posterior cingulate cortex volume of interest, derived from structural MRI;
WBC = whole-brain connectivity values in the posterior cingulate cortex volume of interest, derived from resting functional MRI. HC-PiB
– = PiB-negative healthy controls;
HC-PiB
+ = PiB-positive healthy controls; MCI = PiB-positive patients with mild cognitive impairment.
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below the signiﬁcance threshold (Talairach coordinates 4, 67,
14, z-score 2.97).
Voxel-based morphometry revealed only subtle focal reductions
of grey matter density in subjects with mild cognitive impairment
as compared with PiB-negative healthy controls in the right para-
hippocampal region (Supplementary Fig. 1C and Supplementary
Table 2). Outside of the predeﬁned network, clusters of reduced
cortical density were detected in bilateral middle temporal and
inferior frontal cortex as well as in left precentral cortex and in
proximity to the ventricular system, e.g. adjacent to bilateral thal-
amic regions and the right caudate. However, none of these
clusters showed overlap with the abnormalities observed in
ﬂuorodeoxyglucose-PET and whole-brain connectivity analysis in
the different groups. Also compared with PiB-positive healthy con-
trols, grey matter reductions were found in subjects with mild
cognitive impairment in bilateral hippocampal/parahippocampal
regions. Outside the expected network, clusters with reduced cor-
tical density were observed in inferior temporal cortex as well as in
left thalamic and middle occipital areas. Direct comparison be-
tween PiB-positive healthy controls and PiB-negative healthy con-
trols only revealed minor reductions in the right precentral and
middle frontal gyrus in PiB-positive healthy controls. None of the
detected grey matter reductions showed major overlap with the
changes observed in ﬂuorodeoxyglucose-PET and whole-brain
connectivity analysis in the different groups.
Anatomic overlap: dice coefﬁcient
of similarity
The ﬂuorodeoxyglucose and whole-brain connectivity abnormal-
ities detected in subjects with mild cognitive impairment by
Figure 1 (A) Cortical hubs, identiﬁed by whole-brain functional
connectivity analysis of resting state functional MRI in
PiB-negative healthy controls (HC-PiB
), PiB-positive healthy
controls (HC-PiB
+) and PiB-positive patients with mild cognitive
impairment (MCI). Regions affected by loss of cortical hubs in
patients with mild cognitive impairment and PiB-positive healthy
controls are labelled with circles on (1) lateral (yellow) and (2)
medial (blue) aspects of the right hemisphere (contralateral re-
sults are comparable). (B) Voxel-based statistical group com-
parison between mild cognitive impairment and PiB-negative
healthy controls. (Left) Hypometabolism in mild cognitive im-
pairment as compared to PiB-negative healthy controls
(
18F-ﬂuorodeoxyglucose-PET). (Right) Disrupted cortical hubs in
mild cognitive impairment as compared to PiB-negative healthy
controls. Aspects: 1 = left lateral; 2 = cranial; 3 = right lateral;
4 = dorsal. Signiﬁcance threshold P50.001 (uncorrected).
Figure 2 (A) 3D surface projection of the overlap between
hypometabolic deﬁcits (yellow) and regional disruption of
whole-brain connectivity (WBC) (red) in PiB-positive patients
with mild cognitive impairment (MCI) as compared to
PiB-negative healthy controls at a threshold of P50.001
(uncorrected). Aspects: 1 = left lateral; 2 = cranial; 3 = right lat-
eral; 4 = sagittal left medial; 5 = dorsal; 6 = axial caudal. (B)3 D
volumetric illustration of the overlap between the abnormalities
(in blue). Aspects: 1 = sagittal left lateral; 2 = dorsal; 3 = sagittal
right lateral.
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cingulate cortex/precuneus regions (Fig. 2). Quantitative analysis
using the dice coefﬁcient revealed that ﬂuorodeoxyglucose and
whole-brain connectivity abnormalities showed 42% similarity.
Volumes of interest-based group
comparison
We employed an independently predeﬁned spherical volume in
the posterior cingulate cortex, which has been previously estab-
lished (refer to the ‘Materials and Methods’ section and
Supplementary Material) (Andrews-Hanna et al., 2007). Within
the posterior cingulate cortex volume of interest, statistically sig-
niﬁcant reductions of cerebral metabolism were observed in
patients with mild cognitive impairment but also in PiB-positive
healthy controls, as compared to PiB-negative healthy controls
(Fig. 3B and Table 2). Furthermore, a signiﬁcantly reduced
degree of whole-brain connectivity was observed within this
volume of interest in patients with mild cognitive impairment, as
compared with PiB-negative healthy controls. In PiB-positive
healthy controls, whole-brain connectivity values were numerically
lower as compared with PiB-negative healthy controls and higher
as compared with subjects with mild cognitive impairment; how-
ever, due to high standard deviation, these differences did not
reach signiﬁcance (Fig. 3C and Table 2). No signiﬁcant differences
in grey matter density between subjects with mild cognitive im-
pairment, PiB-negative healthy controls and PiB-positive healthy
controls were found in volume of interest-based analysis.
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Figure 3 Volume of interest based group comparisons (left) and correlation analyses (right). Left: Mean and standard deviation of (A)
glucose metabolism as measured by
18F-ﬂuorodeoxyglucose-PET, (B) amyloid burden measured by
11C-PiB-PET and (C) whole-brain
connectivity (WBC) (cortical hub integrity) as measured by resting-state functional MRI within the posterior cingulate cortex-volume of
interest in PiB-negative healthy controls (HC PiB
), PiB-positive healthy controls (HC PiB
+) and PiB-positive patients with mild cognitive
impairment (MCI). Error bars refer to the standard deviations. Right: Correlation analyses between: (D) glucose metabolism (posterior
cingulate cortex-volume of interest) and amyloid burden (FLR-VOI); (E) whole-brain connectivity (posterior cingulate cortex-volume of
interest) and amyloid burden (FLR-VOI) and (F) glucose metabolism and whole-brain connectivity (both posterior cingulate cortex-volume
of interest) as measured in the entire sample (including PiB-negative healthy controls, PiB-positive healthy controls and PiB-positive
patients with mild cognitive impairment). Number of data points: n = 37. FDG-PET = ﬂuorodeoxyglucose PET; PCC-VOI = independently
predeﬁned spherical volume of interest in the posterior cingulate cortex; rCMRglc = regional cerebral metabolic rate of glucose
consumption; *Signiﬁcant as compared with PiB-negative healthy controls (unpaired t-test, signiﬁcance threshold P50.05).
+signiﬁcant
as compared with PiB-negative healthy controls and to PiB-positive healthy controls (unpaired t-test, signiﬁcance threshold P50.05).
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brain connectivity were unlikely to be due to structural grey
matter differences (Table 2).
Correlation analyses
In volume of interest-based correlation analysis of the imaging
ﬁndings across our entire sample, signiﬁcant negative correlations
were found between PiB-FLR values and ﬂuorodeoxyglucose-values
in the posterior cingulate cortex as well as between PiB-FLR values
and whole-brain connectivity values in the posterior cingulate cortex.
A positive correlation was observed between ﬂuorodeoxyglucose-
values in the posterior cingulate cortex and whole-brain connectivity
values in the posterior cingulate cortex values (Fig. 3D–F and
Table 2). We also found a signiﬁcant negative correlation between
PiB-FLR values and ﬂuorodeoxyglucose values in the posterior
cingulate cortex (r = 0.60) and a trend towards a positive cor-
relation between PiB-FLR and whole-brain connectivity values in
the posterior cingulate cortex (r = 0.54, P=0.06) in the mild cog-
nitive impairment group alone. Including age and regional grey
matter density as potential confounding variables into the analyses
did not substantially alter the detected correlations between ima-
ging modalities (Table 2). For additional results of voxel-based
correlation analysis, see the Supplementary material.
Discussion
The ﬁndings of our study suggest a clear association between
functional disconnection of cortical hubs, reduced neuronal activity
and amyloid burden in predementia stages of Alzheimer’s disease.
The ﬁrst key ﬁnding of the current study is the signiﬁcant disrup-
tion of functional whole-brain connectivity in cortical hub regions
(posterior cingulate/precuneus and temporoparietal cortex) in
amyloid-positive mild cognitive impairment. Furthermore, charac-
teristic hypometabolic abnormalities were also evident in this mild
cognitive impairment sample, demonstrating major topograph-
ical overlap with the connectivity disruptions. Minor reductions
of cerebral glucose metabolism and of functional whole-brain
connectivity were found in amyloid-positive healthy subjects in cor-
responding brain areas. Across the entire sample, higher amyloid
burden correlated with lower whole-brain connectivity and metab-
olism, particularly in the posterior cingulate cortex/precuneus.
Inversely, a positive correlation between metabolism and whole-
brain connectivity was found in this region, supporting the
hypothesis of early amyloid-related dysfunction in this key hub
region.
Our ﬁndings are consistent with several previously published
single modality imaging studies in ageing and early Alzheimer’s
disease. Signiﬁcantly increased uptake of the amyloid-tracer
11C-PiB has been consistently documented in patients with
Alzheimer’s disease with manifest dementia but also in 50–60%
of patients with mild cognitive impairment and even in 20–50% of
elderly healthy subjects (Drzezga, 2010). First studies indicate a
predictive value of elevated PiB uptake in non-demented subjects
with regard to later cognitive decline, suggesting that these ﬁnd-
ings represent early Alzheimer’s disease pathology (Mintun et al.,
2006; Pike et al., 2007; Morris et al., 2009; Okello et al., 2009).
Similar to previous studies, we quantiﬁed overall amyloid burden
in a large cortical region to avoid bias towards a speciﬁc cortical
region (Hedden et al., 2009). We divided subjects into amyloid-
positive and negative according to pre-established cut-off values
and we only included amyloid-positive subjects with mild cogni-
tive impairment to increase the probability that they represent
predementia Alzheimer’s disease (Hedden et al., 2009).
To probe cortical hub integrity, we performed an analysis of
regional whole-brain connectivity on the resting functional MRI
data. With the same technique as applied in our recent study,
functional cortical hubs were consistently identiﬁed in a group of
127 young healthy controls, with maxima in bilateral parietal lob-
ules, the posterior cingulate cortex, medial frontal and superior/
middle frontal cortical regions (Buckner et al., 2009). We identiﬁed
a similar pattern of intact cortical hubs in PiB-negative healthy
controls in our study. In contrast, signiﬁcant whole-brain connect-
ivity disruption was detected in patients with mild cognitive im-
pairment in temporoparietal cortex and posterior cingulate cortex/
precuneus, i.e. typical cortical hub regions. In similar regions, sig-
niﬁcant whole-brain connectivity disruptions were even found in
PiB-positive healthy controls, pointing to early functional abnorm-
alities in this group, possibly long before onset of dementia. To our
knowledge this is the ﬁrst study demonstrating disruption of func-
tional whole-brain connectivity in subjects at risk for Alzheimer’s
disease. As these cortical hubs are thought to play a critical role in
mediating inter-regional communication in the brain (Buckner
et al., 2009; Sepulcre et al., 2010), the breakdown of these im-
portant switch points may contribute to progressive cognitive
dysfunction in Alzheimer’s disease. In addition to these ﬁndings, we
identiﬁed signiﬁcant hypometabolism with
18F-ﬂuorodeoxyglucose-
PET in subjects with mild cognitive impairment, particularly in the
posterior cingulate cortex/precuneus. Since synaptic activity of
neurons is associated with glucose uptake, cerebral hypometabo-
lism can be regarded as a measure of reduced neuronal activity
(Magistretti and Pellerin, 1999). The hypometabolic abnormalities
detected in our study correspond well to ﬁndings reported in pre-
vious studies in patients with Alzheimer’s disease and with pro-
gressive mild cognitive impairment, supporting the notion that our
mild cognitive impairment population included subjects with early
Alzheimer’s disease pathology (Herholz, 1995; Silverman et al.,
2001; Minoshima, 2003; Mosconi et al., 2004; Drzezga et al.,
2005; Reiman et al., 2005; Nobili et al., 2008). The patterns of
hypometabolism and regional cortical hub disruption in mild cog-
nitive impairment showed striking similarity, with a topographical
overlap of 42%, indicating that the two different functional
abnormalities are distinctly regionally interrelated. Volume of inter-
est-based analysis revealed signiﬁcantly lower metabolism in the
posterior cingulate cortex also in PiB-positive healthy controls,
indicating minor metabolic abnormalities were already present in
this cognitively intact group. Altogether, these ﬁndings suggest
that emerging amyloid burden may initiate synaptic dysfunction
and disruptions in the connectivity in corresponding regions.
These ﬁndings are further complemented by the cross-modality
correlation analyses. The positive correlation between metabolism
and cortical hub integrity (whole-brain connectivity values)
observed in posterior cortical hub regions supports the notion
1642 | Brain 2011: 134; 1635–1646 A. Drzezga et al.that neuronal dysfunction and functional disconnection in these
areas may be causally interwoven. Interestingly, lower
ﬂuorodeoxyglucose-PET values in the posterior cingulate cortex
region were correlated with lower whole-brain connectivity
values not only in the posterior cingulate cortex/precuneus, but
also in frontal and cortical regions in unrestricted voxel-based ana-
lysis (see Supplementary Material). Thus, synaptic dysfunction in
the posterior cingulate cortical hub may affect function of remote
brain regions and potentially foster the onset of neurodegenera-
tion in these regions. This underlines the importance of intact
neuronal function in the posterior cingulate cortex as a major cor-
tical hub. The ﬁnding that higher overall amyloid burden was
correlated with lower metabolism and whole-brain connectivity
values in the posterior cingulate cortex/precuneus region suggests
that cortical hub regions may be particularly vulnerable to subse-
quent neurodegeneration induced by elevated amyloid burden.
The values used for the correlation analyses showed a continuous
distribution with a relatively broad overlap between the three sam-
ples rather then group-centred clusters. This indicates that the
detected correlations may not have been only driven by
group-based differences. Supporting this impression, a strong
negative correlation between amyloid burden and
ﬂuorodeoxyglucose-PET values was also present in the mild cog-
nitive impairment sample alone. However, the detected correl-
ations may still in part be based on the differences between the
three groups.
To investigate whether both hypometabolic and functional con-
nectivity changes observed in our study might be due to cortical
brain atrophy as a common underlying pathology, we performed a
voxel based morphometry analysis of the structural MRI data from
all subjects. This analysis revealed focal reductions in cortical grey
matter density in mild cognitive impairment in a pattern corres-
ponding well to results from several previous studies (Bell-McGinty
et al., 2005; Whitwell et al., 2007). The observed grey matter
reductions did not show essential overlap with the abnormalities
detected by ﬂuorodeoxyglucose-PET or functional MRI. Only in
PiB-positive healthy controls, a small reduction in middle frontal
grey matter density may account for the subtle hypometabolism
observed at the same location. In addition, the volume of interest-
based analyses support the notion that the observed functional
changes, as measured with ﬂuorodeoxyglucose-PET and functional
MRI, were not mainly the result of regional cortical atrophy. We
did not perform partial volume correction of our PET data, as there
is no generally accepted method available for partial volume cor-
rection of functional MRI resting state data, particularly not for the
recently introduced cortical hub analyses and we preferred to
compare all different imaging modalities on the same structural
framework. Consequently, some effect of regional atrophy on
our results cannot be excluded, although results from voxel-based
morphometry analysis do not point in this direction.
Regarding the interrelation between amyloid burden, functional
connectivity and metabolism, information from previous studies is
very limited. Impaired functional connectivity in the default mode
network has been demonstrated not only in Alzheimer’s disease
and mild cognitive impairment but also in PiB-positive healthy
controls, particularly affecting connectivity to/from the posterior
cingulate cortex/precuneus region (Rombouts et al., 2005; Sorg
et al., 2007; Hedden et al., 2009). It can be speculated that a
breakdown of cortical hub function may also have contributed to
those results. In another recent study, Cohen et al. (2009) demon-
strated inverse correlations between amyloid burden and cerebral
metabolism in parietal and precuneus cortex in patients with mani-
fest Alzheimer’s disease, corresponding well to our ﬁndings.
However, in contrast to our ﬁndings, they observed positive
correlations between metabolism and PiB uptake in mild cognitive
impairment in several regions, and they did not observe a cor-
relation between PiB- and ﬂuorodeoxyglucose-PET values in
amyloid-positive controls. However, in contrast to our study,
Cohen et al. (2009) related PiB to ﬂuorodeoxyglucose data in a
speciﬁc region-to-region comparison, whereas we assessed overall
amyloid burden. Importantly, Cohen et al. (2009) applied partial
volume correction to their PET data, whereas we did not (for the
reasons explained above). This may also in part explain the differ-
ences between the studies. Finally, hypometabolic abnormalities
have been described in mild cognitive impairment in many previ-
ous studies (Silverman et al., 2001; Chetelat et al., 2003;
Minoshima, 2003; Mosconi et al., 2004; Drzezga et al., 2005),
which may also indicate that patients with mild cognitive impair-
ment examined by Cohen et al. (2009) may have been in earlier
stages of disease than those included in other studies.
Mechanistically, the ﬁndings of our study can be interpreted in
different ways: (i) subtle neuronal loss in cortical hub regions (un-
detected by voxel based morphometry analysis) may have led to
reduced regional energy consumption (hypometabolism) and re-
duction of functional connectivity; (ii) synaptic dysfunction in the
affected areas may have led to reduced connectivity to other brain
regions resulting in lower energy consumption. Vice versa,
reduced metabolic/energetic efﬁciency may have led to impaired
energy provision, limiting synaptic communication with other brain
regions; and (iii) reduced neuronal function of remote brain re-
gions may have led to reduced input into the cortical hub regions,
resulting in reduced synaptic activity and neuronal energy require-
ment. Currently, it remains unknown if the blood oxygen
level-dependent signal in functional MRI studies is driven by re-
gional neuronal output (spikes) or input from remote neurons
(local ﬁeld potentials) (Raichle and Mintun, 2006). Thus, a mixture
of all three hypotheses may explain our results. It has been
recently suggested that speciﬁc properties of cortical hubs may
directly augment the pathological cascade of Alzheimer’s disease.
An anatomical connection with numerous other brain regions may
lead to high functional tension in these regions, i.e. continuously
high levels of activity may predispose them for later neurodegen-
eration (Buckner et al., 2009). It has been demonstrated that pro-
cessing of amyloid peptides depends on regional synaptic activity
(Nitsch et al., 1993; Cirrito et al., 2005) and that aggregated
b-amyloid peptides may exert a direct synaptotoxic effect (Hardy
and Higgins, 1992; Selkoe, 2008). These facts may predispose
cortical hubs for excessive b-amyloid accumulation and consecu-
tive neurodegeneration. In line with this theory, overlap between
cortical hub locations in healthy controls and b-amyloid deposition
in patients with Alzheimer’s disease has been shown (Buckner
et al., 2005, 2009). Complementing these ﬁndings, it has been
observed that cortical hubs are among the brain regions that
demonstrate high levels of ‘aerobic glycolysis’ (excessive glycolysis
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2010). Recently, genetic variation in glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), a key enzyme of glycolysis, has been
proposed as a risk factor for Alzheimer’s disease, indicating a con-
nection between glycolysis and neurodegeneration (Li et al.,
2004). It has been speculated that regions dependent on aerobic
glycolysis may be particularly susceptible to failure of vital mech-
anisms such as glucose-dependent synaptic function or protection
from oxidative stress. Correspondingly, a spatial correlation be-
tween aerobic glycolysis and amyloid deposition has recently
been demonstrated in Alzheimer’s disease and PiB-positive healthy
controls (Vlassenko et al., 2010), including regions affected
by overlapping hypometabolism and whole-brain connectivity
disruption in our study.
Several limitations apply to our study. We hypothesized that
groups of mild cognitive impairment and PiB-positive healthy con-
trols represent individuals in predementia stages of Alzheimer’s
disease. Although, many recent studies point in this direction,
these assumptions can only be veriﬁed by long-term clinical
follow-up studies. Furthermore, we compared ﬁndings derived
from different imaging techniques, which may have different
methodological sensitivity. The results of our study neither clarify
causality of the relationships nor the chronological appearance of
the biomarkers. We did not perform partial volume correction of
the PET data in our study and voxel-based morphometry analysis
may have missed some more subtle structural changes, e.g. in
grey matter thickness. Thus, some effects of regional structural
differences cannot be excluded. It has been demonstrated that
the ApoE genotype may have a relevant impact on the presence
and degree of cerebral abnormalities associated with Alzheimer’s
disease, thus, different ApoE genotypes may also have inﬂuenced
the parameters examined here (see Supplementary Material). This
problem could not be sufﬁciently addressed in the current study,
as we did not have ApoE genotype available for all of our subjects.
It may be an interesting subject for future studies to examine the
effect of the ApoE genotype on the interaction of different brain
pathologies associated with Alzheimer’s disease. Finally, the clinical
subgroups in our study were relatively small and group size and
gender distribution were not perfectly matched. Thus, the ﬁndings
from the current study should be replicated in future studies
including larger samples.
In conclusion, we found anatomically overlapping disruptions
of functional whole-brain connectivity and hypometabolism in
amyloid-positive patients with mild cognitive impairment in pos-
terior brain regions (posterior cingulate/precuneus). To a lesser
extent, similar abnormalities were already present in corresponding
regions in amyloid-positive older adults without cognitive symp-
toms. Both regional disruption of connectivity and hypometabo-
lism were associated with increasing amyloid burden across all
subjects, which indicates that they may represent early functional
consequences of molecular Alzheimer’s disease pathology, evol-
ving prior to clinical onset of dementia. The interrelation between
hypometabolism and disruption of functional connectivity may re-
ﬂect a link between synaptic failure and functional disconnection.
The concentration of these abnormalities in speciﬁc cortical hub
areas indicates that these regions may be particularly susceptible
to early Alzheimer’s disease neurodegeneration, perhaps due to
the increased metabolic demands of maintaining high connectivity.
Dysfunction of cortical hubs may represent an important early
pathophysiological feature of Alzheimer’s disease, contributing to
progressive cognitive impairment.
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